Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Aug 21, 2009; 15(31): 3891-3900
Published online Aug 21, 2009. doi: 10.3748/wjg.15.3891
Published online Aug 21, 2009. doi: 10.3748/wjg.15.3891
Table 2 Predictive power of serological markers for distinguishing between patients with celiac disease at the time of diagnosis and various control groups
| Sensitivity (%) | Specificity (%) | 95% CI | ||
| LR+ | LR- | |||
| Celiac disease vs healthy controls | ||||
| gASCA | 39 | 86 | 2.73 (1.57-4.76) | 0.71 (0.59-0.86) |
| AMCA | 35 | 100 | - | - |
| ACCA | 38 | 94 | 6.36 (2.76-14.4) | 0.66 (0.56-0.79) |
| Any glycans | 66 | 79 | 3.13 (2.08-4.73) | 0.43 (0.31-0.59) |
| Celiac disease vs non-celiac gastrointestinal controls | ||||
| gASCA | 39 | 96 | 9.36 (2.35-37.4) | 0.64 (0.53-0.76) |
| AMCA | 35 | 100 | - | - |
| ACCA | 38 | 98 | 18.1 (2.56-128.5) | 0.64 (0.53-0.76) |
| Any glycans | 66 | 92 | 7.90 (3.05-20.4) | 0.37 (0.27-0.51) |
- Citation: Papp M, Foldi I, Altorjay I, Palyu E, Udvardy M, Tumpek J, Sipka S, Korponay-Szabo IR, Nemes E, Veres G, Dinya T, Tordai A, Andrikovics H, Norman GL, Lakatos PL. Anti-microbial antibodies in celiac disease: Trick or treat? World J Gastroenterol 2009; 15(31): 3891-3900
- URL: https://www.wjgnet.com/1007-9327/full/v15/i31/3891.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.3891